Analytical Data
-
Gene name
EP2
- Application
-
Alternative Names
EP2；Laforin
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q08648
-
Expression Region
1-103aa
-
AA Sequence
MRQRLLPSVTSLLLVALLFPGSSQARHVNHSATEALGELRERAPGQGTNGFQLLRHAVKRDLLPPRTPPYQVHISHREARGPSFRICVDFLGPRWARGCSTGN
-
Molecular Weight
11.4 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
EP2 recombinant proteins are of significant interest in the fields of immunology and biotechnology due to their potential applications in therapeutic development and vaccine design. EP2, a subtype of the prostaglandin E receptor, plays a crucial role in various physiological processes, including inflammation, immune response modulation, and tissue repair. The study of EP2 recombinant proteins is particularly relevant in understanding their role in diseases such as cancer, autoimmune disorders, and infectious diseases. By producing EP2 proteins in a recombinant system, researchers can investigate their structure, function, and interactions at a molecular level, allowing for the identification of novel therapeutic targets and the development of protein-based therapeutics. Additionally, recombinant EP2 proteins serve as valuable tools for drug screening and the development of antibodies that can modulate EP2 signaling pathways. Increasing evidence suggests that targeting the EP2 receptor can provide beneficial effects in treating various conditions, making the study of its recombinant forms critical for advancing therapeutic strategies. Overall, the research on EP2 recombinant proteins not only enhances our understanding of the biological roles of this receptor subtype but also paves the way for innovative approaches in medicine and biotechnology.
